News

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.

Bootstrap Bio...

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my...

"Donald Trump Signs The Pledge" by Michael Vadon 
is licensed under CC BY-SA 2.0.

This is...

Elon Musk
By Justin Kirkland, The Guardian | 03.03.2025

Image “Elon Musk” by Debbie Rowe, Royal Society on
Wikimedia Commons licensed under CC by S.A. 3.0

I got into...

Stop Forced Sterilization graphic
By Julia Métraux, Mother Jones | 02.28.2025

“Stop Forced Sterilization” poster by Rachael Romero,
San Francisco Poster Brigade, 1977
Courtesy of Rachael Romero through Library of Congress...

police officer searches on a keyboard
By Mike Baker, The New York Times | 02.25.2025

As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students...

wheel of DNA
By Staff, GMWatch | 02.24.2025

In an open statement, civil society groups, scientists, and academics are challenging the democratic legitimacy of any conclusions or policy...

graphic of a 'superbaby'
By Staff, The Economist | 02.21.2025

One of the greatest scandals in modern science began with a late-2010s advertisement for HIV-positive couples looking to have children...

gene therapy graphic
By Angus Liu, Fierce Pharma | 02.21.2025

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez.

The New...

DNA graphic
By Angelica Peebles, CNBC | 02.21.2025

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said...

CRISPR graphic on blue background
By Smriti Mallapaty, Nature | 02.20.2025

A two-and-a-half-year-old girl shows no signs of a rare genetic disorder, after becoming the first person to be treated for...